Search results
PNC Financial Services Group Inc. Sells 93,285 Shares of Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 1 day agoPNC Financial Services Group Inc. lowered its stake in Sanofi (NASDAQ:SNY – Free Report) by 48.1% during the fourth quarter, according to the company in its most recent Form ...
Fisher Asset Management LLC Lowers Stock Holdings in Sanofi (NASDAQ:SNY)
ETF DAILY NEWS· 3 days agoFisher Asset Management LLC lessened its stake in shares of Sanofi (NASDAQ:SNY – Free Report) by 4.4% in the 4th quarter, according to its most recent disclosure with the ...
9,852 Shares in Sanofi (NASDAQ:SNY) Acquired by V Square Quantitative Management LLC
ETF DAILY NEWS· 4 days agoV Square Quantitative Management LLC purchased a new position in Sanofi (NASDAQ:SNY – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor ...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 6 days agoMany investors buy shares if they think a development may lead to better financial results. For a stock whose market cap is around just $2.24 billion,...
Sanofi (OTCMKTS:SNYNF) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 3 days agoSanofi (OTCMKTS:SNYNF – Get Free Report) saw a significant drop in short interest in the month of May. As of May 31st, there was short interest totalling 290,700 shares, a ...
Regeneron (REGN) Outperforms Industry YTD: What Lies Ahead?
Zacks via Yahoo Finance· 2 days agoBiotech giant Regeneron Pharmaceuticals REGN is one of the few top biotech companies that has...
Moderna Just Gave Investors Another Reason to Buy the Stock
Motley Fool via Yahoo Finance· 4 days agoThanks to its deep pipeline, it is moving beyond its coronavirus portfolio. The recent approval of...
Regeneron CEO Leonard Schleifer sells over $25 million in company stock By Investing.com
Investing.com· 7 days agoRegeneron (NASDAQ:REGN) Pharmaceuticals, Inc. (NASDAQ:REGN) has reported a series of transactions by...
AbbVie's (ABBV) Skyrizi Gets FDA Nod for Ulcerative Colitis
Zacks· 1 day agoFree Report) announced that the FDA has granted approval to its blockbuster drug, Skyrizi to treat adults with moderately to severely active ulcerative colitis (UC) in the United States. Skyrizi ...
Gateway - Quartz
Quartz· 2 days agoQuartz is a guide to the new global economy for people who are excited by change. We cover business, finance, economics, technology, lifestyle, and leadership.
